Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catherine Shaffer
Erratum: Incretin Mimetics Vie for Slice of Type 2 Diabetes Market
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Related publications
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Which Incretin-Based Therapy for Type 2 Diabetes?
The Lancet
Medicine
Comparison of Efficacy Between Incretin-Based Therapies for Type 2 Diabetes Mellitus
BMC Medicine
Medicine
Incorporating Incretin-Based Therapies Into Clinical Practice for Patients With Type 2 Diabetes
Advances in Therapy
Medicine
Pharmacology
Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Erratum To: Pharmacokinetics in Patients With Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
Clinical Pharmacokinetics
Pharmacology
Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
Vascular Health and Risk Management
Pharmacology
Cardiology
Endocrinology
Public Health
Hematology
Environmental
Cardiovascular Medicine
Medicine
Occupational Health
Metabolism
Diabetes
TCF7L2 Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
